# Profiling and Targeting Epigenetic Marks to Improve Diagnosis and Therapeutic Approaches in Head and Neck Cancer

> **NCT06706973** · — · RECRUITING · sponsor: **European Institute of Oncology** · enrollment: 60 (estimated)

## Conditions studied

- Head and Neck Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06706973
- **Lead sponsor:** European Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-06
- **Primary completion:** 2030-04-04
- **Final completion:** 2030-04-04
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-11-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06706973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06706973, "Profiling and Targeting Epigenetic Marks to Improve Diagnosis and Therapeutic Approaches in Head and Neck Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06706973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*